Navigation Links
Tracing biological pathways

A new chemical process developed by a team of Harvard researchers greatly increases the utility of Positron Emission Tomography (PET) in creating real-time 3-D images of chemical process occurring inside the human body.

This new work by Tobias Ritter, Associate Professor of Chemistry and Chemical Biology, and colleagues holds out the tantalizing possibility of using PET scans to peer into any number of functions inside the bodies of living patients by simplifying the process of creating "tracer" molecules used to create the 3-D images.

For example, imagine a pharmaceutical company developing new treatments by studying the way "micro-doses" of drugs behave in the bodies of living humans. Imagine researchers using non-invasive tests to study the efficacy of drugs aimed at combatting disorders such as Alzheimer's disease, and identify the physiological differences in the brains of patients suffering from schizophrenia and bipolar disorder.

As described in the Nov. 4 issue of Science, the process is a never-before-achieved way of chemically transforming fluoride into an intermediate reagent, which can then be used to bind a fluorine isotope to organic molecules, creating the PET tracers. Often used in combination with CT scans, PET imaging works by detecting radiation emitted by tracer atoms, which can be incorporated into compounds used in the body or attached to other molecules.

"It's extremely exciting," Ritter said, of the breakthrough. "A lot of people said we would never achieve this, but this allows us to now make tracers that would have been very challenging using conventional chemistry."

The new process builds on Ritter's earlier fluorination work, which reduced the risk of damage to the original molecules by reducing the amount of energy needed to create fluorinated compounds, and involved the development of a unique, "late-stage" process that allowed fluorination to take place at the end of a compound's synthesis, eliminating concerns about the extremely short, two-hour half-life of the fluorine isotope used as a tracer.

Ritter's process begins with fluoride, which is chemically altered to create an intermediate molecule, called an "electrophilic fluorination reagent." Armed with that reagent, and using the late-stage fluorination process developed in Ritter's lab, his team is then able to create fluorinated molecules for use in PET imaging.

The breakthrough opens the door to pharmaceutical companies using the relatively simple, non-invasive scans to track how "micro-doses" of drugs behave in living subjects, with the potential payoff coming in vastly more efficient and cheaper drug development.

"One of the most immediate applications of this is in using molecular imaging to give us an understanding of the bio-distribution of a drug," Ritter said. "If a pharmaceutical company is developing a drug to treat schizophrenia, they could use this test to see if it enters the brain. If early tests show it doesn't, they would be able to kill the project before spending a great deal of time and money on it."

The technique could even be used to unlock the physical traits of disorders that until now have been limited to phenomenological descriptions. Using biomarkers related to specific disorders, researchers could use fluorination to identify biological differences between schizophrenia and bipolar disorder, and use that information to develop treatments for both.

"I don't know if we're ever going to reach that point," Ritter said. "But that's what this project may be able to deliver in the long term. The way my group works we want to solve big problems, and we're willing to sacrifice to get there. This is one problem that is worth a little bit of sweat."


Contact: Peter Reuell


Related biology news :

1. BGI and Collaborators Announce New Clues Found in Tracing the Origin of the Deadly E. coli Strain and Appeal for the Sharing of Additional Data
2. Tracing microbes between individuals towards personalized oral health care
3. Tracing natural hazards by taking Earths pulse
4. 3-D long-term bone marrow culture to analyze stromal cell biological function
5. $10 million grant supports biological sciences team at University of Nevada, Reno
6. Potential new drugs plug brains biological vacuum cleaner and target HIV
7. Market transactions and economics in general affect biological invasions
8. Alarm clock gene explains wake-up function of biological clock
9. Possible biological control discovered for pathogen devastating amphibians
10. Biological communities studied at historical WWII shipwrecks along North Carolina
11. Regenerative powers in the animal kingdom explored in special issue of the Biological Bulletin
Post Your Comments:
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, ... for U.S. distribution of its DNA library preparation ... and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq ... the preparation of NGS libraries for liquid biopsies--the ... diagnostic and prognostic applications in cancer and other ...
(Date:10/27/2015)... 27, 2015 In the present market scenario, ... for various industry verticals such as banking, healthcare, defense, ... growing demand for secure & simplified access control and ... as hacking of bank accounts, misuse of users, , ... as PC,s, laptops, and smartphones are expected to provide ...
(Date:10/26/2015)... PALO ALTO, Calif. and LAS ... – Nok Nok Labs , an innovator in ... FIDO Alliance , today announced the launch of its ... the first unified platform enabling organizations to use standards-based ... authentication. The Nok Nok S3 Authentication Suite is ideal ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is an essential ... bound to proteins, copper is also toxic to cells. With a $1.3 million ... (WPI) will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa ...
(Date:11/24/2015)... - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the "Company"), ... Toronto Stock Exchange, confirms that as of the date ... that would cause the recent movements in the Company,s ... About Aeterna Zentaris Inc. . ... Zentaris is a specialty biopharmaceutical company engaged in developing ...
(Date:11/24/2015)... 2015 --> ... "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, ... DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) ... market is expected to reach USD 1,918.6 Million by ... CAGR of 10.1% during the forecast period. ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... The Academy ... Special Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the ... last few years. Many AMA members have embraced this type of racing and several ...
Breaking Biology Technology: